<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2015-02-16</publicationDate>
    
        <volume>2</volume>
        <issue>2</issue>

 
    <startPage>305</startPage>
    <endPage>310</endPage>

	    <publisherRecordId>811</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Lipid Peroxidation and Antioxidant Enzymes Status in Pre and Postmenopausal Breast Cancer</title>

    <authors>
	 


      <author>
       <name>Vikas Shrivastava</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Gunjan Shrivastava</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Manoj Pathak</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Meenu Rai</name>

		
	<affiliationId>3</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Cancer Hospital and Research Institute (CHRI), Gwalior (India).</affiliationName>
    

		
		<affiliationName affiliationId="2">IASCA, ITM-Universe, Gwalior (India).</affiliationName>
    
		
		<affiliationName affiliationId="3">Boston College of professional studies, Gwalior (India).</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">The study was undertaken to asses the Lipid peroxidation and antioxidant enzymes status in pre and post-menopausal breast cancer subjects. Three hundred fifty female human subjects (168 normal healthy &amp; 182 breast cancer subjects) aged between 25 -65 yrs. were selected for the study which were obtained from cancer hospital &amp; research Institute (CHRI), Gwalior. All subjects were divided into four groups; group I (n=84) included premenopausal normal, group II (n=84) contained postmenopausal normal subjects, group III (n=91) included premenopausal breast cancer subjects and group IV (n=91) contained postmenopausal breast cancer subjects. The biochemical investigations e.g. GSH, lipid peroxidation, SOD, catalase &amp; GPx were investigated in all group of subjects. The GSH showed significant reduction (p&lt;0.05) in group III &amp; IV as compared to groups I &amp; II respectively. The lipid peroxidation, SOD, catalase and GPx showed significant elevation (p&lt;0.05) in group III &amp; IV as compared to group I &amp; II respectively. The results of our study have shown higher oxygen free radical production &amp; increased activities of antioxidant enzymes which may be a compensatory regulation of increased oxidative stress. Hence, the co-administration of antioxidants in the initial stages of the disease may be useful to the clinicians to manage the disease.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol2no2/lipid-peroxidation-and-antioxidant-enzymes-status-in-pre-and-postmenopausal-breast-cancer/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Breast cancer</keyword>
      

      
        <keyword> premenopausal</keyword>
      

      
        <keyword> postmenopausal</keyword>
      

      
        <keyword> lipid peroxidation</keyword>
      

      
        <keyword> antioxidants</keyword>
      

      
        <keyword> Oxidative stress</keyword>
      
</keywords>
  </record>
</records>